The decrease in tumor size is accompanied by a decrease in CCR4+ Treg generation both in the peripheral circulation (Figures 5B, 6B) and at the tumor site (Figures 5C, 6C), demonstrating that FOXP3 transcriptionally activates CCR4 in both in vitro and in vivo settings. The gene discussed is CCR4; the disease is neoplasm.